The Klein Law Firm Reminds Investors of a Class Action Filed on Behalf of Intellipharmaceutics International Inc. Shareholders and a Lead Plaintiff Deadline of September 29, 2017 (IPCI)

NEW YORK, NY / ACCESSWIRE / September 6, 2017 / The Klein Law Firm announces that a class action
complaint has been filed on behalf of shareholders of Intellipharmaceutics
International Inc. (NASDAQ: IPCI) who purchased shares between January 14, 2016
and July 26, 2017.

According to the complaint, throughout
the Class Period, the Company issued materially false and misleading statements
and/or failed to disclose that: (1) Intellipharmaceutics failed to conduct a
human abuse liability study to support its Rexista New Drug Application
(“NDA”); (2) the Company did not include abuse-deterrent studies
conducted to support abuse-deterrent label claims related to abuse of the drug
by various pathways; (3) the Company was not submitting sufficient data to
support approval of the NDA; and (4) as a result, Defendants’ statements about
Intellipharmaceutics’ business, operations, and prospects were false and
misleading and/or lacked a reasonable basis.

If you suffered a loss in
Intellipharmaceutics, you have until September 29,
2017 to request that the Court appoint you as lead plaintiff.
Your ability to share in any recovery doesn’t require that you serve as a lead
plaintiff.

If you suffered a loss during the class
period and wish to obtain additional information, please contact Joseph Klein,
Esq. by telephone at 212-616-4899 or visit http://www.kleinstocklaw.com/pslra-sbm/intellipharmaceutics-international-inc?wire=1.

Joseph Klein, Esq. is an experienced
attorney and has also practiced as a Certified Public Accountant. Mr. Klein
represents investors and participates in securities litigations involving
financial fraud throughout the nation. Attorney advertising. Prior results do
not guarantee similar outcomes.

CONTACT:

Joseph Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

SOURCE:
The Klein Law Firm

ReleaseID: 474702